Cite
HARVARD Citation
Mathieu, C. et al. (2016). Efficacy and safety of triple therapy with dapagliflozin add‐on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes. Diabetes, obesity & metabolism. 18 (11), pp. 1134-1137. [Online].